Project: Expression and Purification of the Spike Protein (S) of Covid19 Virus for Diagnostic Purposes and Production of Live Attenuated Viral Vaccines [Funder: NSHA Research & Innovation, Dalhousie Medical Research Foundation, QEII Health Sciences Centre Foundation, IWK Foundation, DGHF, RNS]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Other Funders (Canada)Principal Investigator
Dr Christopher Richardson Christopher RichardsonResearch Location
CanadaLead Research Institution
Dalhousie UniversityResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This study will generate large quantities of coronavirus spike proteins that can be used to produce immune diagnostic kits and in subunit vaccines directed at COVID-19.